INVO BioScience Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2015
2016
2017
2018
Cash & Short Term Investments
492.00
152.40
25.80
212.20
Total Accounts Receivable
1.30
2.80
86.70
225.90
Inventories
65.40
85.20
58.90
43.50
Other Current Assets
-
11.00
63.10
249.50
Total Current Assets
558.80
251.40
234.40
731.10
Net Property, Plant & Equipment
-
15.70
15.70
34.40
Intangible Assets
21.00
19.10
16.30
11.80
Total Assets
579.80
286.20
266.40
777.30
ST Debt & Current Portion LT Debt
220.90
220.90
210.90
Accounts Payable
1,025.50
974.90
960.70
Other Current Liabilities
3,090.40
3,576.40
3,955.20
Total Current Liabilities
4,336.80
4,772.20
5,126.80
Long-Term Debt
-
131.70
131.70
Total Liabilities
4,336.80
4,903.90
5,258.50
Common Equity (Total)
3,757.00
4,617.60
4,992.10
Total Shareholders' Equity
3,757.00
4,617.60
4,992.10
Total Equity
3,757.00
4,617.60
4,992.10
Liabilities & Shareholders' Equity
579.80
286.20
266.40

About INVO BioScience

View Profile
Address
407R Mystic Avenue
Medford Massachusetts 02155
United States
Employees -
Website http://www.invobioscience.com
Updated 07/08/2019
INVO BioScience, Inc. is a medical device company, which focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Medford, MA.